Literature DB >> 14697863

Large animal models of fulminant hepatic failure in artificial and bioartificial liver support research.

M-P van de Kerkhove1, R Hoekstra, T M van Gulik, R A F M Chamuleau.   

Abstract

Among the large range of organs involved in the field of tissue engineering (skin, blood vessels, cartilage, etc.) the liver has been given broad attention in the last decade. Liver support systems encompassing artificial and bioartificial systems are applied to treat patients with fulminant hepatic failure (FHF) as a bridge to orthotopic liver transplantation or to liver regeneration. To test safety, technical applicability and therapeutic effect of liver support systems, reliable animal models are needed. Due to the complexity of FHF many diverse attempts have been made to develop an adequate animal model to study liver failure, liver regeneration and liver support systems. In this paper an overview is given of the different models and their advantages and disadvantages are discussed. Suggestions are made for the most suitable large animal model to test liver support systems.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14697863     DOI: 10.1016/s0142-9612(03)00509-x

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  10 in total

1.  A Macaca mulatta model of fulminant hepatic failure.

Authors:  Ping Zhou; Jie Xia; Gang Guo; Zi-Xing Huang; Qiang Lu; Li Li; Hong-Xia Li; Yu-Jun Shi; Hong Bu
Journal:  World J Gastroenterol       Date:  2012-02-07       Impact factor: 5.742

2.  Hybrid bioartificial liver support in cynomolgus monkeys with D-galactosamine-induced acute liver failure.

Authors:  Zhi Zhang; Yi-Chao Zhao; Yuan Cheng; Guo-Deng Jian; Ming-Xin Pan; Yi Gao
Journal:  World J Gastroenterol       Date:  2014-12-14       Impact factor: 5.742

3.  Inducing Acute Liver Injury in Rats via Carbon Tetrachloride (CCl4) Exposure Through an Orogastric Tube.

Authors:  Dmitry Frank; Shiri Savir; Benjamin F Gruenbaum; Israel Melamed; Julia Grinshpun; Ruslan Kuts; Boris Knyazer; Alexander Zlotnik; Max Vinokur; Matthew Boyko
Journal:  J Vis Exp       Date:  2020-04-28       Impact factor: 1.355

Review 4.  Acute liver failure: a critical appraisal of available animal models.

Authors:  Mireille Bélanger; Roger F Butterworth
Journal:  Metab Brain Dis       Date:  2005-12       Impact factor: 3.584

5.  Cell-free DNA as a potential marker to predict carbon tetrachloride-induced acute liver injury in rats.

Authors:  Benjamin Fredrick Gruenbaum; Matthew Boyko; Bertha Delgado; Amos Douvdevany; Shaun Evan Gruenbaum; Israel Melamed; Micky Gideon; Evaldas Cesnulis; Yoram Shapira; Alexander Zlotnik
Journal:  Hepatol Int       Date:  2012-11-22       Impact factor: 6.047

Review 6.  An overview of animal models for investigating the pathogenesis and therapeutic strategies in acute hepatic failure.

Authors:  María-Jesús Tuñón; Marcelino Alvarez; Jesús-M Culebras; Javier González-Gallego
Journal:  World J Gastroenterol       Date:  2009-07-07       Impact factor: 5.742

7.  Early myocardial injury is an integral component of experimental acute liver failure - a study in two porcine models.

Authors:  Nikolaos Papoutsidakis; Nikolaos Arkadopoulos; Vassilios Smyrniotis; Helen Tzanatos; Konstantinos Kalimeris; Konstantinos Nastos; George Defterevos; Agathi Pafiti; Georgia Kostopanagiotou
Journal:  Arch Med Sci       Date:  2011-05-17       Impact factor: 3.318

8.  Establishment of a Novel Simplified Surgical Model of Acute Liver Failure in the Cynomolgus Monkey.

Authors:  Lei Cai; Jun Weng; Lei Feng; Guolin He; Jiasheng Qin; Zhi Zhang; Yang Li; Qing Peng; Zesheng Jiang; Mingxin Pan; Yi Gao
Journal:  Biomed Res Int       Date:  2016-12-21       Impact factor: 3.411

9.  A novel, simplified, and reproducible porcine model of acute ischemic liver failure with portal vein preservation.

Authors:  Weisong Xue; Yu Fu; Haojie Zhang; Guoping Li; Peihua Cao; Yang Li; Qing Peng; Kebo Zhong; Shuangtang Feng; Yi Gao
Journal:  Exp Anim       Date:  2021-09-08

10.  A breakthrough trial of an artificial liver without systemic heparinization in hyperbilirubinemia beagle models.

Authors:  Yilin Wang; Shanshan Wang; Xueqin He; Yupei Li; Tao Xu; Lin Xu; Bo Yang; Xinnian Fan; Weifeng Zhao; Changsheng Zhao
Journal:  Bioact Mater       Date:  2022-07-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.